FDA Inspection 1153894 — Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy
The FDA completed an inspection of Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy on September 10, 2021 in Bozeman, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bozeman, MT (United States)